MADRIGAL PHARMACEUTICALS INC. - COMMON STOCK
319.58
01-11月-24 15:59:58
15 分の遅延
株式
+60.24
+23.23%
本日の幅
262.85 - 321.19
ISIN
N/A
ソース
NASDAQ
-
Madrigal Pharmaceuticals Provides Corporate Updates and Reports Third Quarter 2023 Financial Results
06 11 2023 08:00:01 提供 Nasdaq GlobeNewswire
-
Madrigal Pharmaceuticals Announces Participation at Three Upcoming Investor Conferences
02 11 2023 16:05:00 提供 Nasdaq GlobeNewswire
-
Madrigal Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
12 10 2023 16:05:00 提供 Nasdaq GlobeNewswire
-
Madrigal Pharmaceuticals Announces Pricing of $500 Million Public Offering
28 9 2023 22:30:00 提供 Nasdaq GlobeNewswire
-
Madrigal Pharmaceuticals Announces Proposed Public Offering
28 9 2023 16:01:00 提供 Nasdaq GlobeNewswire
-
Madrigal Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
14 9 2023 16:30:00 提供 Nasdaq GlobeNewswire
-
13 9 2023 09:10:00 提供 Nasdaq GlobeNewswire
-
Madrigal Pharmaceuticals Appoints Bill Sibold as Chief Executive Officer
11 9 2023 07:00:00 提供 Nasdaq GlobeNewswire
-
08 8 2023 08:00:01 提供 Nasdaq GlobeNewswire
-
17 7 2023 08:00:01 提供 Nasdaq GlobeNewswire
-
22 6 2023 03:30:00 提供 Nasdaq GlobeNewswire
-
Madrigal Pharmaceuticals Supports International NASH Day on June 8
06 6 2023 08:00:02 提供 Nasdaq GlobeNewswire
-
Madrigal Pharmaceuticals Announces Participation at Two Upcoming Investor Conferences
01 6 2023 08:00:02 提供 Nasdaq GlobeNewswire
-
Madrigal Pharmaceuticals to Participate in the JMP Securities Life Sciences Conference
11 5 2023 08:00:02 提供 Nasdaq GlobeNewswire
-
Madrigal Pharmaceuticals Provides Corporate Updates and Reports First Quarter 2023 Financial Results
09 5 2023 08:00:02 提供 Nasdaq GlobeNewswire
-
18 4 2023 08:00:01 提供 Nasdaq GlobeNewswire
-
23 2 2023 08:00:02 提供 Nasdaq GlobeNewswire
-
Madrigal Pharmaceuticals Announces Participation at Three Upcoming Investor Conferences
08 2 2023 08:00:01 提供 Nasdaq GlobeNewswire
-
06 1 2023 08:00:00 提供 Nasdaq GlobeNewswire